Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026)
Ascendis Pharma A's (ASND) Debt Ratio stood at 0.17 in the quarter ended Jun 30, 2026, down 80.4% from 0.86 a year earlier and down 70.0% from the prior quarter.
Powered by 
Analysis
Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026) Analysis & Trends
For the year ended Dec 31, 2025, Ascendis Pharma A's Debt Ratio came in at 0.82, up 165.5% from the prior year.
- Across earlier years, Debt Ratio came in at 0.31 in the year ended Dec 31, 2024 (-66.9%), 0.94 in the year ended Dec 31, 2023 (+163.4%), 0.36 in the year ended Dec 31, 2022 (+625.4%) and 0.05 in the year ended Dec 31, 2021.
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Debt Ratio since the quarter ended Dec 31, 2021.
- On a year-over-year basis, Debt Ratio rose in three of the last eight quarters, with an average decline of 2.2%.
- Peak year-over-year performance for Debt Ratio in the last five years was growth of 625.4% in the quarter ended Dec 31, 2022, against a decline of 80.4% in the quarter ended Jun 30, 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at 0.56 (quarter ended Mar 31, 2026), 0.82 (quarter ended Dec 31, 2025) and 0.86 (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 0.24 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 0.52 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 0.42 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 0.31 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 0.00 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 0.60 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 0.53 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 0.31 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | Ascendis Pharma A | 14.26 Bn | 10.50 Bn | 362.22 Mn | 0.17 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.17 |
| Mar 31, 2026 | 0.56 |
| Dec 31, 2025 | 0.82 |
| Sep 30, 2025 | 0.86 |
| Jun 30, 2025 | 0.86 |
| Mar 31, 2025 | 0.92 |
| Dec 31, 2024 | 0.31 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 1.07 |
| Mar 31, 2024 | 1.06 |
| Dec 31, 2023 | 0.94 |
| Sep 30, 2023 | 0.63 |
| Jun 30, 2023 | 0.58 |
| Mar 31, 2023 | 0.50 |
| Dec 31, 2022 | 0.36 |
| Sep 30, 2022 | 0.42 |
| Jun 30, 2022 | 0.38 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.05 |
API Access
Ascendis Pharma A Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=ASND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "ASND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=ASND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();